Advertisement
Loading...

Indivior Pharmaceuticals Inc

INDV•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$36.76
$-1.07(-2.83%)
U.S. Market opens in 28h 26m

Indivior Pharmaceuticals Inc (INDV) Stock Overview

Explore Indivior Pharmaceuticals Inc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.6B
P/E Ratio18.40
EPS (TTM)$1.95
ROE-1.42%
Fundamental Analysis

AI Price Forecasts

1 Month$31.89
3 Months$38.47
1 Year Target$25.20

INDV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Indivior Pharmaceuticals Inc (INDV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.40 and a market capitalization of 4.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.83%
5-Day Change
-7.59%
1-Month Change
13.04%
3-Month Change
6.30%
6-Month Change
20.56%
Year-to-Date (YTD) Change
2.45%
1-Year Change
232.07%
3-Year Change
94.29%
5-Year Change
250.10%
All-Time (Max) Change
245.16%

Contact Information

https://www.indivior.com
804 379 1090
10710 Midlothian Turnpike, North Chesterfield, VA, 23235

Company Facts

1,030 Employees
IPO DateDec 29, 2014
CountryUS
Actively Trading

Frequently Asked Questions